Pharma tax news - Vol. 5, No. 8 - September 2006

New temporary regulations address key Section 482 rules

The IRS recently issued temporary and proposed regulations on the treatment of controlled services transactions under section 482, and the allocation of income with respect to intangibles contributed by a controlled party. The temporary regulations also modify the regulations under section 861 regarding “stewardship” expenses to be consistent with the changes made to the section 482 regulations. While the guidance is meant to be taxpayer-favorable, Pharma companies may find some issues to be worthy of further consideration.





Publications Search Page
Contacts
Global
Simon Friend
Pharmaceuticals and life sciences leader
Tel: +44 (20) 7213 4875
Mike Swanick
Pharmaceuticals and life sciences tax leader
Tel: +1 (267) 330 6060
Dr. Steve Arlington
Pharmaceuticals and life sciences advisory leader
Tel: +44 (20) 7804 3997
 

© 2006-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
Accessibility information Skip navigation Countries online